PODCAST of dr. Robin Cornelissen about efficacy and safety of poziotinib in treatment-naïve NSCLC harboring HER2 exon 20 mutations
Ariez Publishing
PODCAST of dr. Robin Cornelissen about efficacy and safety of poziotinib in treatment-naïve NSCLC harboring HER2 exon 20 mutations
00:00 / 06:13